These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 22394185)
1. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide). McInnes SJ; Irani Y; Williams KA; Voelcker NH Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185 [TBL] [Abstract][Full Text] [Related]
2. New biodegradable materials produced by ring opening polymerisation of poly(L-lactide) on porous silicon substrates. McInnes SJ; Thissen H; Choudhury NR; Voelcker NH J Colloid Interface Sci; 2009 Apr; 332(2):336-44. PubMed ID: 19200556 [TBL] [Abstract][Full Text] [Related]
3. Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior. Bodiford NK; McInnes SJP; Voelcker NH; Coffer JL Biomed Microdevices; 2018 Aug; 20(3):71. PubMed ID: 30097808 [TBL] [Abstract][Full Text] [Related]
4. A novel pressed porous silicon-polycaprolactone composite as a dual-purpose implant for the delivery of cells and drugs to the eye. Irani YD; Tian Y; Wang M; Klebe S; McInnes SJ; Voelcker NH; Coffer JL; Williams KA Exp Eye Res; 2015 Oct; 139():123-31. PubMed ID: 26277579 [TBL] [Abstract][Full Text] [Related]
5. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating. McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169 [TBL] [Abstract][Full Text] [Related]
6. Combination of iCVD and porous silicon for the development of a controlled drug delivery system. McInnes SJ; Szili EJ; Al-Bataineh SA; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH ACS Appl Mater Interfaces; 2012 Jul; 4(7):3566-74. PubMed ID: 22720638 [TBL] [Abstract][Full Text] [Related]
7. Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications. Ryu J; Cho B; Woo HG; Cho S; Sohn H J Nanosci Nanotechnol; 2013 Jan; 13(1):157-60. PubMed ID: 23646711 [TBL] [Abstract][Full Text] [Related]
8. Stimulus-responsiveness and drug release from porous silicon films ATRP-grafted with poly(N-isopropylacrylamide). Vasani RB; McInnes SJ; Cole MA; Jani AM; Ellis AV; Voelcker NH Langmuir; 2011 Jun; 27(12):7843-53. PubMed ID: 21604788 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
10. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications. Mori M; Almeida PV; Cola M; Anselmi G; Mäkilä E; Correia A; Salonen J; Hirvonen J; Caramella C; Santos HA Eur J Pharm Biopharm; 2014 Nov; 88(3):635-42. PubMed ID: 25305585 [TBL] [Abstract][Full Text] [Related]
12. Structure, morphology and cell affinity of poly(L-lactide) films surface-functionalized with chitosan nanofibers via a solid-liquid phase separation technique. Zhao J; Han W; Tang M; Tu M; Zeng R; Liang Z; Zhou C Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1546-53. PubMed ID: 23827607 [TBL] [Abstract][Full Text] [Related]
13. Homogeneous chitosan/poly(L-lactide) composite scaffolds prepared by emulsion freeze-drying. Niu X; Li X; Liu H; Zhou G; Feng Q; Cui F; Fan Y J Biomater Sci Polym Ed; 2012; 23(1-4):391-404. PubMed ID: 21255484 [TBL] [Abstract][Full Text] [Related]
14. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin. Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937 [TBL] [Abstract][Full Text] [Related]
15. Porous silicon-cyclodextrin based polymer composites for drug delivery applications. Hernandez-Montelongo J; Naveas N; Degoutin S; Tabary N; Chai F; Spampinato V; Ceccone G; Rossi F; Torres-Costa V; Manso-Silvan M; Martel B Carbohydr Polym; 2014 Sep; 110():238-52. PubMed ID: 24906752 [TBL] [Abstract][Full Text] [Related]
17. A poly(lactide) stereocomplex structure with modified magnesium oxide and its effects in enhancing the mechanical properties and suppressing inflammation. Kum CH; Cho Y; Seo SH; Joung YK; Ahn DJ; Han DK Small; 2014 Sep; 10(18):3783-94. PubMed ID: 24820693 [TBL] [Abstract][Full Text] [Related]
18. A comparative study on the in vivo degradation of poly(L-lactide) based composite implants for bone fracture fixation. Wang Z; Wang Y; Ito Y; Zhang P; Chen X Sci Rep; 2016 Feb; 6():20770. PubMed ID: 26857951 [TBL] [Abstract][Full Text] [Related]
19. Responsive delivery of drug cocktail via mesoporous silica nanolamps. Muhammad F; Guo M; Wang A; Zhao J; Qi W; Guo Y; Zhu G J Colloid Interface Sci; 2014 Nov; 434():1-8. PubMed ID: 25151090 [TBL] [Abstract][Full Text] [Related]
20. Surface modification of bioactive glass nanoparticles and the mechanical and biological properties of poly(L-lactide) composites. Liu A; Hong Z; Zhuang X; Chen X; Cui Y; Liu Y; Jing X Acta Biomater; 2008 Jul; 4(4):1005-15. PubMed ID: 18359672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]